Alfred B Kupferberg, Deceased

Title: Alfred B. Kupferberg: A Legacy of Innovation in Anti-Viral Agents

Introduction

Alfred B. Kupferberg was a notable inventor whose contributions to the field of anti-viral agents have left a lasting impact. Based in Somerville, NJ, he was known for his innovative work in developing nonionic surface active agents that serve as effective inactivating agents for herpes simplex. His dedication to research and development is reflected in his patent portfolio.

Latest Patents

Kupferberg held a total of 3 patents during his career. His latest patents focused on nonionic surface active anti-viral agents. These agents are described as nonionic surfactants that are particularly useful in inactivating herpes simplex viruses. His work in this area has contributed significantly to the understanding and potential treatment of viral infections.

Career Highlights

Throughout his career, Kupferberg was associated with Ortho Pharmaceutical Corporation, where he applied his expertise in the development of pharmaceutical products. His innovative spirit and commitment to scientific advancement were evident in his research endeavors.

Collaborations

Kupferberg collaborated with several notable individuals in his field, including Samuel S. Asculai and By Meyer Halpern, Coexecutor. These collaborations helped to enhance the scope and impact of his work in anti-viral research.

Conclusion

Alfred B. Kupferberg's contributions to the field of anti-viral agents exemplify the spirit of innovation and dedication to scientific progress. His legacy continues to influence research in the area of viral inactivation.